Phase 1, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the effects of erenumab (AMG 334) and concomitant sumatriptan on blood pressure in healthy volunteers - de Hoon, Jan; Van Hecken, Anne; Vandermeulen, Corinne; Herbots, Marissa; Kubo, Yumi; Lee, Ed; Eisele, Osa; Vargas, Gabriel; Gabriel, Kristin (Cephalalgia, 2019)
Keywords: Adult; Antibodies, Monoclonal, Humanized - pharmacology; Blood Pressure - drug effects; Calcitonin Gene-Related Peptide Receptor Antagonists - pharmacology; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Healthy Volunteers; Humans; Male; Migraine Disorders - drug therapy; Original; Serotonin 5-HT1 Receptor Agonists - pharmacology; Sumatriptan - pharmacology; clinical trial; blood pressure; migraine; safety; pharmacokinetics; Erenumab; sumatriptan